CLS patients had increased Ki67‐CD38+, Ki67‐HLA‐DR+, and Ki67‐TIM3+ cells at mid‐cycle (Figure 5E–G), and also decreased Ki67+ DR+ cells at this time point (Figure 5H). Here, HAVCR2 is linked to capillary leak syndrome.